Scripps Research Scientists Discover Molecular Defect
Involved in Hearing Loss
May 2009
Editor: Another week, another important discovery about how we hear
that takes us one step closer to being able to prevent and/or reverse
hearing loss. This one involves the importance of a protein that mediates
the process of converting mechanical vibrations to electrical signals
within the cochlea.
~~~~~~~~~~~~~~~~~
Scientists from The Scripps Research Institute have elucidated the
action of a protein, harmonin, which is involved in the mechanics of
hearing. This finding sheds new light on the workings of
mechanotransduction, the process by which cells convert mechanical stimuli
into electrical activity. Defects in mechanotransduction genes can cause
devastating diseases, such as Usher's syndrome, which is characterized by
deafness, gradual vision loss, and kidney disease, which can lead to
kidney failure.
The research, led by Scripps Research Professor Ulrich Mueller, was
published in the May 14, 2009 issue of the journal Neuron.
"We're constantly confronted with mechanical signals of many different
kinds and we have sensors all over our bodies that respond to those
signals," Mueller says. "For example, mechanosensors in the muscles
control posture, while those in skin allow us to feel touch. Though many
of our other senses, such as taste and smell, are well understood,
mechanosensory perception is a world about which we know next to nothing."
By gaining a better appreciation of the molecular mechanics of hearing,
scientists can learn a great deal about the workings of similar types of
body processes and the defects in these processes that can cause disease.
Hearing: An Exquisite Molecular Dance
Sound starts as waves of mechanical vibrations that travel through the
air to the ear by compressing air molecules. The waves first hit the outer
ear, then travel down the ear canal into the middle ear before striking
the eardrum. The vibrating eardrum moves a set of delicate bones that
communicate with a fluid-filled spiral structure in the inner ear, the
cochlea. Inside the cochlea are specialized "hair cells" lined with
symmetric arrays of stereocilia-mechanosensing organelles that respond to
fluid motion or fluid pressure changes. The movement of the fluid inside
the cochlea causes the stereocilia, in turn, to move.
When sterocilia are deflected, molecular complexes called "tip links,"
which connect the tips of stereocilia, transmit physical force to the
gated ion channels that are attached to them. The opening of these ion
channels, which are monitored by sensory neurons, communicate the
electrical signals to neurons in the brain, enabling hearing. In Usher
syndrome and some other sensory neuronal diseases that cause deafness, the
symmetry of the stereocilia-and the process of mechanotransduction-is
disrupted, resulting in deafness.
"It has been known for some time that defects in the hair cells make
people deaf, but no one knew why-it was thought that perhaps synapses in
the hair cells somehow degenerate or the cells don't develop normally,"
Mueller says. "The idea that the hair cells' basic function as
mechanotransducers were impaired as a result of molecular defects has
never been shown before."
Building on Earlier Research
In part because stereocilia are extremely small, scarce, and difficult
to handle, the molecules that make up the tip link remained elusive until
2007, when Mueller and his colleagues identified cadherin 23 and
protocadherin 15 as the two proteins responsible for opening the ion
channels. They also showed that cadherin 23 formed a complex with another
protein, myosin 1c, which helped close the channel.
"Cadherin 23 and protocadherin 15 were two of the first known
components of any mechanotransduction machinery of sensory cells in
vertebrates," Mueller says. "Having these two components, we then went
looking for others and found harmonin, which localizes to the tip link
where cadherin 23 is also localized, and which we now know is required for
mechanotransduction."
Having identified harmonin as yet another molecule involved in
mechanotransduction, scientists may be able to move a little closer to
addressing a basic science puzzle: How do biological systems build gating
systems that act as mechanical devices, almost like switches? Similar
switches are present in almost every cell in the body and are the
gatekeepers that let ions flow in and out of a cell. Any given cell might
have hundreds or thousands of channels. The right stimulus can throw a
channel open, allowing ions to pass through; the surge of ions across the
cell membrane generates tiny electrical currents that enable a multitude
of bodily functions.
"Many different diseases are related to mechanical phenomena," Mueller
says. "Understanding the components of this machinery may help shed light
on many of them, leading ultimately to new treatments."
The first authors of the paper, "Harmonin (protein) mutations cause
mechanotransduction defects in cochlear hair cells," are Nicolas Grillet,
Wei Xiong, and Anna Reynolds of Scripps Research. Additional authors
include Takashi Sato and Bechar Kachar of the National Institute of
Deafness and other Communication Disorders, National Institutes of Health
(NIH); Conception Lillo and David Williams of the University of
California, Los Angeles, School of Medicine; Rachel Dumont and Peter
Gillespie of the Oregon Health & Science University; and Piotr Kazmierczak,
Edith Hintermann, Anna Sczaniecka, and Martin Schwander of Scripps
Research.
The work was funded by the NIH, the Skaggs Institute for Chemical
Biology, a Jules and Doris Stein RPB professorship, a C.J. Martin
fellowship NHMRC (Australia), and a fellowship from the Bruce Ford and
Anne Smith Bundy Foundation.
About The Scripps Research Institute
The Scripps Research Institute is one of the world's largest
independent, non-profit biomedical research organizations, at the
forefront of basic biomedical science that seeks to comprehend the most
fundamental processes of life. Scripps Research is internationally
recognized for its discoveries in immunology, molecular and cellular
biology, chemistry, neurosciences, autoimmune, cardiovascular, and
infectious diseases, and synthetic vaccine development. Established in its
current configuration in 1961, it employs approximately 3,000 scientists,
postdoctoral fellows, scientific and other technicians, doctoral degree
graduate students, and administrative and technical support personnel.
Scripps Research is headquartered in La Jolla, California with a second
campus located in Jupiter, Florida. Research at Scripps Florida focuses on
basic biomedical science, drug discovery, and technology development.